Home › Compare › EMOR vs MCD

EMOR vs MCD: Dividend Comparison 2026

EMOR yields 5000.00% · MCD yields 2.35%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EMOR wins by $62217131802825.27M in total portfolio value
10 years
EMOR
EMOR
● Live price
5000.00%
Share price
$0.04
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$62217131802825.35M
Annual income
$59,861,980,287,378,210,000.00
Full EMOR calculator →
MCD
McDonald's Corporation
● Live price
2.35%
Share price
$308.53
Annual div
$7.26
5Y div CAGR
42.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$78.5K
Annual income
$26,227.70
Full MCD calculator →

Portfolio growth — EMOR vs MCD

📍 EMOR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEMORMCD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EMOR + MCD cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
EMOR pays
MCD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EMOR
Annual income on $10K today (after 15% tax)
$425,000.00/yr
After 10yr DRIP, annual income (after tax)
$50,882,683,244,271,480,000.00/yr
MCD
Annual income on $10K today (after 15% tax)
$200.01/yr
After 10yr DRIP, annual income (after tax)
$22,293.55/yr
At 15% tax rate, EMOR beats the other by $50,882,683,244,271,450,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EMOR + MCD for your $10,000?

EMOR: 50%MCD: 50%
100% MCD50/50100% EMOR
Portfolio after 10yr
$31108565901412.71M
Annual income
$29,930,990,143,689,118,000.00/yr
Blended yield
96.21%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MCD right now

EMOR
No analyst data
Altman Z
-337.8
Piotroski
4/9
MCD
Analyst Ratings
37
Buy
23
Hold
1
Sell
Consensus: Buy
Price Target
$351.76
+14.0% upside vs current
Range: $320.00 — $385.00
Altman Z
4.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EMOR buys
0
MCD buys
0
No recent congressional trades found for EMOR or MCD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEMORMCD
Forward yield5000.00% ✓2.35%
Annual dividend / share$2.00$7.26 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%42.3% ✓
Portfolio after 10y$62217131802825.35M ✓$78.5K
Annual income after 10y$59,861,980,287,378,210,000.00 ✓$26,227.70
Total dividends collected$62057786341622.61M ✓$58.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary

Year-by-year: EMOR vs MCD ($10,000, DRIP)

YearEMOR PortfolioEMOR Income/yrMCD PortfolioMCD Income/yrGap
1← crossover$510,700$500,000.00$10,815$334.85+$499.9K → EMOR
2$24,410,935$23,864,485.98$11,826$491.71+$24.40M → EMOR
3$1,092,192,501$1,066,072,800.30$13,123$730.06+$1092.18M → EMOR
4$45,746,366,951$44,577,720,975.17$14,853$1,100.07+$45746.35M → EMOR
5$1,793,932,828,410$1,744,984,215,772.56$17,257$1,690.61+$1793932.81M → EMOR
6$65,871,973,805,320$63,952,465,678,921.49$20,752$2,667.01+$65871973.78M → EMOR
7$2,265,146,887,602,700$2,194,663,875,631,007.20$26,103$4,354.83+$2265146887.58M → EMOR
8$72,954,689,148,998,180$70,530,981,979,263,280.00$34,794$7,437.78+$72954689148.96M → EMOR
9$2,201,076,182,660,884,700$2,123,014,665,271,456,500.00$49,926$13,461.60+$2201076182660.83M → EMOR
10$62,217,131,802,825,350,000$59,861,980,287,378,210,000.00$78,550$26,227.70+$62217131802825.27M → EMOR

EMOR vs MCD: Complete Analysis 2026

EMOR — Stock

Healixa Inc. operates as a technology company with assets in both healthtech and fintech. It offers tech solutions to enterprise partner channels across a range of industries, including employer benefits, travel, pharma, logistics, and other. Healixa Inc. also operates digital pharmacy marketplace. The company was formerly known as Emerald Organic Products Inc. and changed its name to Healixa Inc. in April 2021. The company was founded in 1977 and is based in Holbrook, New York.

Full EMOR Calculator →

MCD — Consumer Discretionary

McDonald's Corporation operates and franchises McDonald's restaurants in the United States and internationally. Its restaurants offer hamburgers and cheeseburgers, chicken sandwiches and nuggets, wraps, fries, salads, oatmeal, shakes, desserts, sundaes, soft serve cones, bakery items, soft drinks, coffee, and beverages and other beverages, as well as breakfast menu, including biscuit and bagel sandwiches, breakfast burritos, hotcakes, and other sandwiches. As of December 31, 2021, the company operated 40,031 restaurants. McDonald's Corporation was founded in 1940 and is headquartered in Chicago, Illinois.

Full MCD Calculator →
📬

Get this EMOR vs MCD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EMOR vs SCHDEMOR vs JEPIEMOR vs OEMOR vs KOEMOR vs MAINEMOR vs YUMEMOR vs QSREMOR vs SBUX

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.